Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134595) titled 'T Cell Function Reboot Strategy for Anti-Tumor Research' on Oct. 16.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Guangxi Medical University Cancer Hospital

Condition: nasopharyngeal carcinoma

Recruitment Status: Recruiting

Phase: 0

Date of First Enrollment: 2026-06-03

Target Sample Size: Case series:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=320729

Disclaimer: Curated by HT Syndication....